Therapeutic Effect of Intense Pulsed Light (IPL) Combined with Meibomian Gland Expression (MGX) on Meibomian Gland Dysfunction (MGD)

Table 1

Clinical assessments of pre- and posttreatment.

	Pretreatment	Posttreatment
OSDI (score)	36.07 ± 1.67	30.04 ± 1.93	<0.001
TBUT (s)	9.58 ± 3.04	7.52 ± 0.80	0.385
TMH (cm)	0.18 ± 0.01	0.20 ± 0.07	0.003
Meibomian gland assessments
Secretion quality (0–3)	1.98 ± 0.80	1.61 ± 0.89	0.001
Expressibility (upper, 0–9)	6.73 ± 2.09	5.63 ± 2.28	0.001
Expressibility (lower, 0–9)	7.12 ± 2.10	5.74 ± 2.36	0.001
Eyelid margin abnormalities
Telangiectasia (0/1)	0.70 ± 0.46	0.50 ± 0.50	0.001
Irregular (0/1)	0.81 ± 0.90	0.72 ± 0.45	0.030
Corneal staining (score)	0.77 ± 2.54	0.30 ± 2.38	0.022

values of less than 0.05 were considered statistically significant and are expressed as ^∗.